Infectious disease

According to Fauci, kids can safely go trick-or-treating outdoors this Halloween. He did add that children who are eligible for COVID-19 vaccinations should do so for an “extra degree of protection.”
If authorized, it could be available in the U.S. before the end of the year. It is also working to submit applications to other regulators worldwide.
Another busy week for clinical trial news. Here’s a look.
As US vaccination rates have been hovering in the 50% of the population range for two months, President Biden hit the old dusty trail to push his vaccine mandate even more.
Here’s a look at mRNA vaccines and their effectiveness and more COVID-19 news.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The question is continually being raised: what offers superior protection, a vaccine against COVID-19 or natural immunity?
Moderna seeks to invalidate two patents of Arbutus Biopharma Corp. The company hopes to appeal a preemptive challenge to the patents upheld by the U.S. Patent Trial and Appeals Board.
There is a noted discrepancy between the price the U.S. government has agreed to pay Merck for the drug and the actual manufacturing costs.
FDA
There is — still — plenty of news about COVID-19 and new drugs, therapies and FDA applications. Here’s a look.
PRESS RELEASES